OXB (LSE: OXB) (“the Company”), a global quality and innovation-led cell and gene therapy CDMO, provides an update to ...

RNA gene scissors (CRISPR-Cas13) are gaining significant attention as a next-generation gene therapy with fewer side effects.

ROCKVILLE, Md., June 11, 2025 /PRNewswire/ -- Ascend Advanced Therapies (Ascend), a gene-to-GMP development partner, has ...

ScaleReady, in collaboration with Wilson Wolf Manufacturing, Bio-Techne Corporation and CellReady, today announced that Immuneel Therapeutics has been awarded a $150,000 G-Rex® Grant to support ...

Public health experts have emphasised the urgent need for Nigeria to adopt life-changing gene therapy for the treatment of ...

Gene therapy experts and advocates warning of the sector’s many challenges found a receptive audience in FDA leadership at a ...

Bionova Scientific opened its plasmid DNA production and development facility on May 29 in an effort to provide gene and cell ...

Sarepta is the first company to publicly disclose that it's received the designation, for which the FDA had issued a draft guidance last year.

Leaders from the world of cell and gene therapy shared their personal stories and policy recommendations in an extraordinary ...

The Platform Technology Designation, which predates the current FDA leadership, is designed to streamline the drug ...

Researchers have identified an early postnatal window that allows gene transfer to circulating blood stem cells, advancing ...